Cybin (CYBN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CYBN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry ProgramsApril 21, 2025 | tmcnet.comCybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato citedMarch 13, 2025 | msn.comTANG CAPITAL MANAGEMENT LLC Increases Stake in Cybin IncFebruary 14, 2025 | gurufocus.comCybin stock price target cut to $150 at H.C. WainwrightFebruary 13, 2025 | msn.comH.C. Wainwright Sticks to Their Buy Rating for Cybin (CYBN)February 5, 2025 | markets.businessinsider.comCybin files $650M mixed securities shelfJanuary 9, 2025 | markets.businessinsider.comCybin to Discuss Breakthrough Treatments at Fireside ChatDecember 4, 2024 | markets.businessinsider.comTANG CAPITAL MANAGEMENT LLC Increases Stake in Cybin IncDecember 3, 2024 | gurufocus.comCybin price target lowered to $86 from $96 at CanaccordNovember 14, 2024 | markets.businessinsider.comCybin Inc: Another High-Risk Psychedelics PlayNovember 3, 2024 | seekingalpha.comEXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines ProgramOctober 24, 2024 | msn.comCybin: Top Value Psychedelic StockOctober 15, 2024 | seekingalpha.comPsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in Upcoming Water Tower Research Fireside ChatOctober 3, 2024 | msn.comPsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Reports on Status of Key Clinical MilestonesSeptember 20, 2024 | msn.com'We're Pretty Cheap At The Moment' - Cybin CEO Doug DrysdaleSeptember 19, 2024 | seekingalpha.comCybin Inc (R7E1.BE)August 30, 2024 | nz.finance.yahoo.comCybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive DisorderAugust 13, 2024 | finance.yahoo.comCybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business HighlightsAugust 8, 2024 | stockhouse.comCybin to Participate in the Canaccord Genuity 44th Annual Growth ConferenceAugust 7, 2024 | finance.yahoo.comBest Stocks Under $1 To Buy NowMay 20, 2024 | msn.comCybin to Participate at the 27th Annual Milken Institute Global ConferenceApril 25, 2024 | finance.yahoo.comCybin launches $150M oversubscribed private placementMarch 13, 2024 | seekingalpha.comCybin Inc. (CYBN) stock price, news, quote & history – Yahoo FinanceFebruary 11, 2024 | sg.finance.yahoo.comFN MEDIA GROUP LLC: How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) ConditionJanuary 24, 2024 | finanznachrichten.deCybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028January 8, 2024 | finance.yahoo.comCybin (CYBN) Price Target Increased by 44.08% to 5.39December 16, 2023 | msn.comPsyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And MoreDecember 5, 2023 | msn.comCybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?December 3, 2023 | msn.comAnalysts Offer Insights on Healthcare Companies: Cybin (CYBN), ADMA Biologics (ADMA) and Halozyme (HALO)November 17, 2023 | markets.businessinsider.comCybin Reports Second Quarter Financial Results and Recent Business HighlightsNovember 14, 2023 | finance.yahoo.comCybin Announces Closing of Offering of Units Led by One of the Company’s Largest Institutional ShareholdersNovember 14, 2023 | businesswire.comCybin Announces up to US$64 Million Offering of UnitsNovember 10, 2023 | finance.yahoo.comCompelling Factors Bolster Buy Rating for Cybin Inc.: Emphasis on Promising Phase 2 Trial Results and Strategic AcquisitionsNovember 3, 2023 | markets.businessinsider.comCybin to Participate at the 2023 Milken Institute Future of Health SummitNovember 3, 2023 | finance.yahoo.comSingle Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results FindNovember 1, 2023 | benzinga.comCybin Provides Corporate Update and Highlights Key Upcoming Milestones Across its Development PipelineNovember 1, 2023 | finance.yahoo.comCybin Announces Positive Phase 2 Interim Data For CYB003 In Major Depressive Disorder; Stock UpOctober 31, 2023 | markets.businessinsider.comCybin Announces Results of Annual and Special Meeting of ShareholdersOctober 12, 2023 | finance.yahoo.comCybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For DepressionSeptember 26, 2023 | benzinga.comPsyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And MoreSeptember 26, 2023 | benzinga.comCybin Announces Agreement with Fluence to Support Scaling of EMBARK Training for CYB003 Phase 3 TrialSeptember 26, 2023 | finance.yahoo.comCybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major DepressionSeptember 21, 2023 | benzinga.comCybin Announces Date of Annual and Special Meeting of ShareholdersSeptember 21, 2023 | finance.yahoo.comCybin skyrockets as Steve Cohen’s hedge fund Point72 purchases almost 19M sharesSeptember 18, 2023 | proactiveinvestors.comBillionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge UpdateSeptember 18, 2023 | benzinga.comCybin Shares Rise After Offer to Buy Small PharmaAugust 29, 2023 | marketwatch.comFunding The Future Of Psychedelics: Cybin Launches Renewed ATM Equity Program Up To $35MAugust 24, 2023 | benzinga.comCybin renews $35M ATM equity offeringAugust 24, 2023 | msn.comCybin Prepares for GMP Manufacturing of CYB003 Capsules for Phase 3 TrialAugust 17, 2023 | finance.yahoo.comPsychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen LibraryAugust 16, 2023 | benzinga.com Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address CYBN Media Mentions By Week CYBN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYBN News Sentiment▼0.000.84▲Average Manufacturing News Sentiment CYBN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYBN Articles This Week▼00▲CYBN Articles Average Week Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PBH News Today BHC News Today CRON News Today TLRY News Today AIM News Today ITH News Today CRDL News Today APM News Today GXE News Today GPH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CYBN) was last updated on 6/9/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Knows Exactly What He's DoingREVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cybin Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cybin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
